New pill hopes to slow Parkinson's in early stages
Disease control
Completed
This study tested a new drug called vutiglabridin in 99 people with early Parkinson's disease. Participants took either the drug or a placebo daily for 24 weeks. The goal was to see if the drug is safe and can help control symptoms like movement problems. The study is complete, b…
Phase: PHASE2 • Sponsor: Glaceum • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC